Efficacy Study of Sodium Channel Blocker in LQT3 Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by University of Rochester
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Wojciech Zareba, University of Rochester
ClinicalTrials.gov Identifier:
NCT01648205
First received: July 18, 2012
Last updated: December 30, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)